Name | JDB175 |
---|
Description | JDB175 is a highly selective BTK inhibitor with oral activity and excellent blood-brain barrier penetration. JDB175 shows good activity in the mouse model of central nervous system lymphoma without obvious signs of toxicity, effectively inhibits the proliferation of BTK signaling pathway of human lymphoma cells, induces cell cycle arrest, and promotes cell apoptosis [1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C26H21F3N4O2 |
---|---|
Molecular Weight | 478.47 |